Therefore, to test our hypothesis, we screened for NHE9 expression a diverse panel of 10 patient-derived GBM cell lines, established from samples obtained from the operative room at the Johns Hopkins Hospital and propagated in serum-free medium (Fig. 1B). Here, SLC9A9 is linked to glioblastoma.